{"id":"fluval-ab-vaccination","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain, redness, or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1821846","moleculeType":"Small molecule","molecularWeight":"676.71"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) influenza A and B virus antigens that trigger both humoral and cellular immune responses. Upon vaccination, the immune system recognizes these antigens and generates specific antibodies and memory cells that provide protection against infection with circulating influenza strains during the flu season.","oneSentence":"Fluval AB is an inactivated influenza A and B vaccine that stimulates the immune system to produce antibodies against seasonal influenza viruses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:46:45.485Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza A and B prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT01863849","phase":"PHASE4","title":"Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2013-08-22","conditions":"Influenza Prophylaxis","enrollment":120},{"nctId":"NCT02387294","phase":"PHASE3","title":"Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2014-10","conditions":"Human Influenza","enrollment":120},{"nctId":"NCT01649713","phase":"PHASE4","title":"Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2012-08","conditions":"Influenza","enrollment":120},{"nctId":"NCT01407978","phase":"NA","title":"Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2009-08","conditions":"Novel 2009 Influenza H1N1, Influenza, Human","enrollment":58},{"nctId":"NCT01404182","phase":"PHASE4","title":"Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2011-07","conditions":"Influenza","enrollment":121},{"nctId":"NCT01408290","phase":"NA","title":"Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2011-09","conditions":"Influenza","enrollment":256},{"nctId":"NCT01459276","phase":"NA","title":"A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2011-10","conditions":"Influenza","enrollment":1206},{"nctId":"NCT01010893","phase":"NA","title":"Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2009-08","conditions":"Influenza","enrollment":355}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Fluval AB vaccination","genericName":"Fluval AB vaccination","companyName":"Fluart Innovative Vaccine Ltd, Hungary","companyId":"fluart-innovative-vaccine-ltd-hungary","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluval AB is an inactivated influenza A and B vaccine that stimulates the immune system to produce antibodies against seasonal influenza viruses. Used for Seasonal influenza A and B prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}